Competitor Novo Nordisk gains market share in weight loss drugs

Novo Nordisk will capture a larger share of the weight loss drug market within the next 6 months as competitors like Hims struggle with sales shortfalls. Its established pipeline and brand recognition will drive growth.

Implied probability (Yes)

80%